These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19020376)

  • 21. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
    Scaroni C; Ceccato F; Rizzati S; Mantero F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
    Arita K; Hirano H; Tominaga A; Kurisu K
    Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult growth hormone replacement using a fixed graded initiation phase followed by an individualised titration phase: a single centre experience.
    Prague J; Taylor C; Al-Zaman Y; Lecka A; Oguntolu V; Miell J; McGregor A; Aylwin S
    Horm Res; 2007; 68 Suppl 5():204. PubMed ID: 18174748
    [No Abstract]   [Full Text] [Related]  

  • 24. Is safety of childhood growth hormone therapy related to dose? Data from a large observational study.
    Sävendahl L; Pournara E; Pedersen BT; Blankenstein O
    Eur J Endocrinol; 2017 Mar; 176(3):X1. PubMed ID: 28159881
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature.
    Giampietro A; Milardi D; Bianchi A; Fusco A; Cimino V; Valle D; Marana R; Pontecorvi A; De Marinis L
    Fertil Steril; 2009 Mar; 91(3):930.e7-11. PubMed ID: 19046578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment approaches of growth failure.
    Rappaport R
    Pediatr Endocrinol Rev; 2008 Dec; 6(2):257. PubMed ID: 19209477
    [No Abstract]   [Full Text] [Related]  

  • 27. Central hypothyroidism and growth hormone treatment: clinical care.
    Lania A; Giavoli C; Ferrante E; Beck-Peccoz P
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):66-70. PubMed ID: 19020390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics in growth, and pituitary tumorigenesis. Preface.
    Dunger DB; Popović-Brkić V
    Horm Res; 2009 Apr; 71 Suppl 2():1. PubMed ID: 19407489
    [No Abstract]   [Full Text] [Related]  

  • 29. The future of research into growth hormone responsiveness.
    Rosenfeld RG
    Horm Res; 2009 Apr; 71 Suppl 2():71-4. PubMed ID: 19407500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network of European studies of genes in growth (NESTEGG).
    Johnston LB; Ester W; Caliebe J; Molinas C; Wollmann H; Fryklund L; Clark AJ; Ranke MB; Tauber M; Hokken Koelega A; Savage MO
    Horm Res; 2009 Apr; 71 Suppl 2():48-54. PubMed ID: 19407497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update from the GHMonitorSM observational registry in children treated with recombinant human growth hormone (Saizen).
    Plotnick L; Rapaport R; Desrosiers P; Fuqua JS
    Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():278-82. PubMed ID: 19337182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME; Karlsson H
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empty sella may be the final outcome in lymphocytic hypophysitis.
    Karaca Z; Tanriverdi F; Unluhizarci K; Kelestimur F; Donmez H
    Endocr Res; 2009; 34(1-2):10-7. PubMed ID: 19557587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA; Arnhold IJ
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical management of growth hormone therapy in adults.
    Salvatori R
    Manag Care; 2009 Aug; 18(8 Suppl 6):10-6. PubMed ID: 19760984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIGS: 20 years.
    Ranke M
    Horm Res; 2007; 68 Suppl 5():40. PubMed ID: 18174705
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal and observational studies module.
    Lassere MN
    J Rheumatol; 1999 Feb; 26(2):459-68. PubMed ID: 9972988
    [No Abstract]   [Full Text] [Related]  

  • 40. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.